Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Board Changes

1 Nov 2024 07:00

RNS Number : 4424K
Redcentric PLC
01 November 2024
 

Redcentric plc

 

("Redcentric" or the "Group")

 

Board Changes

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, confirms that further to the announcement on 24 September 2024, John Radziwill has been appointed as non-executive director of the Company after completing the relevant due diligence as part of the onboarding process for all new board appointments. Mr Radziwill joins the board as a representative of ND Capital Investments Limited ("ND Capital"), one of the Company's largest shareholders, and is a highly experienced director. Mr Radziwill has held several senior leadership roles in investment banking, advisory and asset management.

Relationship Agreement

In conjunction with Mr Radziwill's appointment, the Company has entered into a relationship agreement with ND Capital. The key terms of this agreement are as follows:

· ND Capital has the right to nominate one person for appointment as a director of the Company providing that ND Capital (together with its individual partners and their affiliates), directly or indirectly, holds no less than 15 per cent of the voting rights of the Company (or 7.5 per cent taking into account any reduction in voting rights resulting from any dilution following the date of the agreement);

· All transactions, agreements or arrangements entered into between a member of the Group and ND Capital and/or any of its associates will be conducted at arm's length and on arm's length commercial terms; 

· ND Capital shall exercise its voting rights to ensure, so far as it is able to do so by the exercise of such rights, that directors independent of ND Capital shall at all times constitute a majority of the Redcentric board (save with the approval of a majority of the independent directors);

· ND Capital and its associates will not propose any resolution or other action to cancel the trading of the Company's shares from trading on AIM without the board's approval (save with the approval of a majority of the independent directors); and

· ND Capital and its associates will not solicit proxies unless consistent with the recommendation of the board, exercise powers to requisition a shareholders' meeting, or undertake any action to obtain or consolidate control of the Company or seek to do so, otherwise than in accordance with the Takeover Code.

Richard McGuire, Chair of Redcentric, commented:

"John brings a wealth of expertise and experience to the Group. His addition further strengthens the Board composition and capabilities to drive execution of the Group's strategic initiatives. John represents one of the Company's long-standing and major investors through his role at ND Capital, and we look forward to his valuable insights and contributions in advancing Redcentric's strategy."

Additional information with regard to John Radziwill:

The following information is disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

Full name: John Stanislas Albert Radziwill

Age: 77

Current directorships:

StoneX Group Inc.

Oryx International Growth Fund Ltd.

Seatboost Inc.

GGH Management 2 Sp. z o. o.

GGH Management 3 Sp z o.o.

StoneX Switzerland SA

Netsurion LLC (formerly known as VendorSafe Technologies Inc.)

Furnari Sp.z.o.o.

Previous directorships held in the past 5 years:

GGH MT Sp. z o. o.

Fifth Street Capital (BVI)

 

Save as set out above there are no further disclosures required pursuant to Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies.

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

Cavendish Capital Markets Limited - Nomad and Sole Broker +44 (0)20 7220 0500

Marc Milmo / Callum Davidson / Rory Sale (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZMFGMMDGDZM
Date   Source Headline
12th Jul 20227:00 amRNSAcquisition of Sungard data centres and 4D
7th Jul 20226:25 pmRNSCompletion of Acquisitions
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
9th Jun 20227:00 amRNSDirector/PDMR Shareholding
7th Jun 20228:07 amRNSAcquisition of business and assets of Sungard
12th May 20227:00 amRNSDirectorate Change
28th Apr 20227:00 amRNSTrading Update
27th Apr 20227:00 amRNSNew £100m Bank Facilities
21st Apr 20227:00 amRNSExercise of Options
17th Mar 20227:00 amRNSExercise of Options
15th Mar 20227:00 amRNSAcquisition of 7 Elements Limited
24th Feb 202211:29 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSHolding(s) in Company
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSResponse to outcome of FCA criminal prosecutions
2nd Feb 20221:43 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSTransaction in Own Shares
19th Jan 20227:00 amRNSHolding(s) in Company
14th Jan 20227:00 amRNSTransaction in Own Shares
10th Jan 20227:00 amRNSTransaction in Own Shares
6th Jan 20227:00 amRNSTransaction in Own Shares
5th Jan 20227:00 amRNSTransaction in Own Shares
4th Jan 20227:00 amRNSTransaction in Own Shares
31st Dec 202112:27 pmRNSHolding(s) in Company
30th Dec 20217:00 amRNSTransaction in Own Shares
29th Dec 20217:00 amRNSHolding(s) in Company
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20214:48 pmRNSSave As You Earn Option Scheme
17th Dec 20218:22 amRNSNotice of subscription of warrants
24th Nov 20216:20 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Nov 20215:30 pmRNSDividend Update
19th Nov 20217:00 amRNSGrant of Options and Director/PDMR Shareholding
18th Nov 20217:01 amRNSHalf Year Results
18th Nov 20217:00 amRNSBoard changes
8th Nov 20212:58 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSTrading Update
20th Oct 20217:00 amRNSIssue of Equity
12th Oct 20217:00 amRNSExercise of Options
5th Oct 20217:00 amRNSIssue of Equity
30th Sep 20217:00 amRNSAcquisition of Piksel Industry Solutions Limited
29th Sep 20217:00 amRNSExercise of Options
9th Sep 20214:11 pmRNSResult of AGM
31st Aug 20217:00 amRNSSave As You Earn Share Option Scheme
9th Aug 20217:00 amRNSPublication of Annual Report and Notice of AGM
26th Jul 20217:00 amRNSIssue of Equity
23rd Jul 20212:55 pmRNSHolding(s) in Company
23rd Jul 202111:26 amRNSHolding(s) in Company
15th Jul 20217:00 amRNSPreliminary Results Announcement FY21
8th Jul 20217:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.